Related Experiment Video

Updated: Aug 3, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Immunoglobulin GM and KM genotypes in hepatitis C virus infection

Sasijit Vejbaesya1, Taweesak Tanwandee, Janardan P Pandey

  • 1Department of Transfusion Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. sisve@mahidol.ac.th

Journal of Medical Virology
|June 2, 2004
PubMed

Insights

Immunoglobulin (Ig) GM and KM gene variants influence Hepatitis C virus (HCV) susceptibility. Specific GM genotypes are associated with increased risk of persistent chronic HCV infection, impacting global liver disease burden.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection affects over 170 million globally, causing diverse liver conditions.
  • Understanding host genetic factors influencing HCV infection outcomes is crucial for public health.
  • Immunoglobulin (Ig) allotypes, including GM and KM genes, are potential modulators of infectious disease susceptibility.

Purpose of the Study:

  • To investigate the association between immunoglobulin (Ig) GM and KM gene polymorphisms and Hepatitis C virus (HCV) infection in a Thai population.
  • To determine if specific GM or KM genotypes correlate with the development of transient versus persistent chronic HCV infection.

Main Methods:

  • Case-control study involving 191 HCV-infected Thai subjects (43 transient, 148 chronic) and 134 healthy controls.
  • Genotyping of GM and KM alleles was performed using polymerase chain reaction (PCR)-based techniques.
  • Statistical analysis compared allele frequencies between patient groups and controls.

Main Results:

  • A significantly lower frequency of G1M(f) homozygotes was observed in HCV patients compared to controls (52.4% vs. 64.2%, P = 0.03).
  • Conversely, a higher frequency of G1M(z) homozygotes was found in HCV patients than in controls (10.5% vs. 3.7%, P = 0.02).
  • These findings indicate a statistically significant difference in specific GM genotype distributions between infected individuals and healthy controls.

Conclusions:

  • GM genotypes appear to play a significant role in determining the risk of acquiring Hepatitis C virus (HCV) infection.
  • Host genetic factors, specifically GM allotypes, may influence susceptibility to persistent chronic HCV infection.
  • Further research into immunogenetic factors could inform strategies for managing HCV infection and liver disease.

More Related Videos

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes07:58

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

Published on: March 6, 2019

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...